You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 14, 2025

Drug Price Trends for AZURETTE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for AZURETTE

Average Pharmacy Cost for AZURETTE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
AZURETTE 28 DAY TABLET 51862-0890-01 0.17061 EACH 2025-01-22
AZURETTE 28 DAY TABLET 51862-0890-06 0.17061 EACH 2025-01-22
AZURETTE 28 DAY TABLET 75907-0091-62 0.17061 EACH 2025-01-22
AZURETTE 28 DAY TABLET 75907-0091-28 0.17061 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Azurette

Overview of Azurette

Azurette is a combined oral contraceptive (COC) that contains desogestrel and ethinyl estradiol. It is indicated for the prevention of pregnancy in women who choose this method of contraception. The drug is available in a biphasic regimen, consisting of 21 dark blue tablets containing desogestrel and ethinyl estradiol, 2 green tablets containing only ethinyl estradiol, and 5 light-blue tablets containing ethinyl estradiol[1][3][5].

Market Demand and Usage

Oral contraceptives, including Azurette, remain highly effective and popular methods of contraception. The demand for these products is consistent, driven by the need for reliable and convenient birth control options. The efficacy of Azurette, like other COCs, depends on the reliability with which it is used, with correct and consistent use resulting in lower failure rates[1][3][5].

Pricing and Cost Considerations

As of the current market, the cost for Azurette biphasic oral tablets is approximately $103 for a supply of 168 tablets, which can vary depending on the pharmacy and location[4].

Insurance Coverage

Insurance companies are more likely to cover generic versions of drugs, such as Azurette and its equivalent Kariva, due to their lower costs compared to brand-name versions. This makes Azurette a more affordable option for many users, especially those with insurance coverage[5].

Generic vs. Brand-Name

Azurette, being a generic version, is generally cheaper than its brand-name counterparts. This pricing advantage contributes to its market appeal, especially in a healthcare environment where cost is a significant factor in treatment choices[5].

Price Projections

Current Trends

The pharmacy market outlook for 2025 suggests a stable pricing environment for many pharmaceuticals. According to the Vizient Pharmacy Market Outlook, the overall drug price inflation rate for 2025 is projected to be around 0%, indicating that prices for drugs like Azurette are likely to remain relatively stable[2].

Future Considerations

While specific price projections for Azurette are not provided in the available data, the general trend of stable pharmaceutical prices in 2025 suggests that the cost of Azurette is unlikely to increase significantly. However, factors such as changes in manufacturing costs, regulatory changes, or shifts in market demand could influence future pricing.

Market Competition

Azurette competes in the market with other combined oral contraceptives, including its equivalent Kariva and brand-name versions like Mircette. The competition is based on factors such as efficacy, side effect profile, and cost. Azurette's generic status and lower cost make it a competitive option in the market[5].

Consumer and Prescriber Preferences

Consumer preferences often lean towards affordable and effective treatments. Azurette's lower cost and equivalent efficacy to brand-name options make it an attractive choice for many women seeking contraception. Prescribers also favor generic options due to their cost-effectiveness and the potential for better patient compliance[5].

Regulatory and Safety Considerations

The use of Azurette and other oral contraceptives is associated with certain risks, such as thromboembolic events, arterial thromboembolism, and other serious cardiovascular conditions. These risks are well-documented and must be considered by both prescribers and users. Regulatory bodies continue to monitor these risks, and any changes in safety profiles could impact market demand and pricing[1][3].

Key Takeaways

  • Stable Pricing: The overall drug price inflation rate for 2025 is projected to be around 0%, suggesting stable prices for Azurette.
  • Cost-Effectiveness: Azurette is a cost-effective option compared to brand-name versions, making it more likely to be covered by insurance.
  • Market Demand: The demand for oral contraceptives remains consistent, driven by the need for reliable birth control options.
  • Regulatory Considerations: The safety profile of Azurette and other oral contraceptives is closely monitored, and any changes could impact market dynamics.

FAQs

  1. What is the typical cost of Azurette? The cost for Azurette biphasic oral tablets is approximately $103 for a supply of 168 tablets, depending on the pharmacy[4].

  2. Is Azurette covered by insurance? Yes, insurance companies are more likely to cover generic versions like Azurette due to their lower costs[5].

  3. How does Azurette compare to brand-name versions? Azurette is generally cheaper than its brand-name counterparts and offers equivalent efficacy[5].

  4. What are the projected price trends for Azurette in 2025? The overall drug price inflation rate for 2025 is projected to be around 0%, indicating stable prices for Azurette[2].

  5. What are the potential risks associated with using Azurette? Azurette is associated with risks such as thromboembolic events, arterial thromboembolism, and other serious cardiovascular conditions[1][3].

Sources

  1. Drugs.com: Azurette Package Insert / Prescribing Information.
  2. Vizient Inc.: Pharmacy Market Outlook Summer 2024.
  3. RxList: Azurette (Desogestrel/ethinyl Estradiol and Ethinyl Estradiol Tablets).
  4. Drugs.com: Azurette Prices, Coupons, Copay Cards & Patient Assistance.
  5. Healthline: Azurette or Kariva: Which Birth Control Pill Is Right for You?

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.